The classic Starling principle proposed that microvascular fluid exchange was determined
by a balance of hydrostatic and oncotic pressures relative to the vascular wall and this …

Microvascular endothelial cells (CMECs) oxidative damage resulting from
hypoxia/reoxygenation (H/R) injury is responsible for microcirculation perfusion …

Aims Lack of gadolinium-contrast wash-in on first-pass perfusion imaging, early gadolinium-
enhanced imaging, or late gadolinium-enhanced (LGE) cardiovascular magnetic resonance …

Coronary no‐reflow occurs commonly during acute percutaneous coronary intervention,
particularly in patients with acute myocardial infarction and those with degenerated vein …

Background—The investigation of no-reflow phenomenon after percutaneous coronary
intervention (PCI) in patients with acute ST-segment–elevation myocardial infarction has …

Coronary heart disease is the largest major killer of American men and women and
accounted for 1 of every 6 deaths in the United States in 2007. 1 The annual incidence of …

The no-reflow phenomenon has been studied extensively in the basic science laboratory
and has entered the clinical arena. No-reflow, which develops largely within the first 2h of …

Coronary artery diseases and particularly acute myocardial infarction are the leading causes
of mortality and morbidity in western countries. Despite the achievements of the last decades …

Microvascular obstruction (MVO) commonly occurs following percutaneous coronary
interventions (PCI), may lead to myocardial injury, and is an independent predictor of …

Microvascular obstruction (MO) or no-reflow phenomenon is an established complication of
coronary reperfusion therapy for acute myocardial infarction. It is increasingly recognized as …